LYMPHOBLASTIC LEUKEMIA
Clinical trials for LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare leukemia: drug combo enters first human tests
Disease control Not yet recruitingThis early-stage trial tests whether combining two drugs, blinatumomab and revumenib, is safe for people with a rare form of acute lymphoblastic leukemia (ALL) caused by a KMT2A gene change. The study will enroll 20 adults, including those whose cancer has returned or not respond…
Matched conditions: LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:44 UTC
-
New combo shot and pill aims to tame tough leukemia
Disease control Not yet recruitingThis study tests whether giving two drugs together—blinatumomab as a shot under the skin and olverembatinib as a pill—can help control a fast-growing blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). About 60 adults with newly diagnosed or r…
Matched conditions: LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:56 UTC